New York City, NY -- (SBWIRE) -- 10/07/2013 -- StockMarketIntel.com issues a special report on the following stocks: Federal Home Loan Mortgage Corp (OTCBB:FMCC), Himax Technologies, Inc. (ADR) (NASDAQ:HIMX), Rite Aid Corporation (NYSE:RAD), Idera Pharmaceuticals Inc (NASDAQ:IDRA)
Federal Home Loan Mortgage Corp (OTCBB:FMCC) trading on 3.37 million shares, to end the trade at $1.41. The stock changed hands in a range of $1.37 to $1.45, bringing its market capitalization to about $916.56 million. If we look at its trading history of the past 52 weeks, the share price suffered a low of $0.24 and was moved to the maximum level of $5.00. Federal Home Loan Mortgage Corporation (Freddie Mac) conducts business in the United States residential mortgage market and the global securities market. The Company operates in three segments: Single-family Guarantee, Investments, and Multifamily.
Can Investors Bet on FMCC after this News update? Find out in this Research Report
Himax Technologies, Inc. (ADR) (NASDAQ:HIMX) added 1.39%, to complete the trading session at $10.94, with a total volume of 10.07 million shares. The stock, on average, trades on a volume of 12.95 million shares. It floated in a range of $10.89 to $11.30 during the last trading session, with a beta value of 1.92. Its market capitalization now moved to about $1.86 billion. In the past 52 weeks, the share price has not declined below $1.77 and above $11.49. Himax Technologies, Inc. operates as an IC design house with LCD manufacturing capability. The Company focuses on display IC products for display device and offers LCD technical consulting to customers to provide them with value-added technical support and integrated solutions.
Why Should Investors Buy HIMX After The Recent Gain? Just Go Here and Find Out
Rite Aid Corporation (NYSE:RAD) added 2.17 and was in a range of $5.13-$5.26 before closing at $5.19. The stock completed the day with a total volume of 47.42 million shares, versus an average volume of 31.66 million shares. The share price hit its 52-week low of $0.95and $5.30 was the best price. Rite Aid Corporation is a retail drugstore chain in the United States. As of March 3, 2013, it operated 4,623 stores in 31 states across the country and in the District of Columbia. In the Company’s stores, it sells prescription drugs and a range of other merchandise, which it calls front end products.
Will RAD Continue To Move Higher? Find Out Here
Idera Pharmaceuticals Inc (NASDAQ:IDRA) added 16.73%, bringing its market capitalization around $133.64 million. The share price, after opening at $2.75, made a high of $3.12 and hovered above $2.70 to end the day at $2.86. The total number of shares that changed hands during the session was 10.59 million shares, as compared to average trading volume of 1.36 million shares. Idera Pharmaceuticals, Inc. is a clinical-stage biotechnology company engaged in the discovery and development of novel synthetic deoxyribonucleic acid (DNA) - and ribonucleic acid (RNA) - based drug candidates. The Company is developing drug candidates that are designed to modulate immune responses mediated through Toll-like Receptors (TLRs). It is also evaluating gene silencing oligonucleotides (GSOs), which inhibit the production of disease-associated proteins by targeting RNA.
What was the Moving Force behind IDRA on Bullish Run? Read This Research Report
Never invest in any stock featured on our site or emails unless you can afford to lose your entire investment. The disclaimer is to be read and fully understood before using our site, or joining our email list.
Neither StockMarketIntel.com, nor its employees and affiliates are registered as investment advisors or broker/dealers in any jurisdiction whatsoever. Through use of this website viewing or using you agree to hold StockMarketIntel.com, its operators, owners, employees, and affiliates harmless and to completely release them from any and all liability due to any and all loss (monetary or otherwise), damage (monetary or otherwise), or injury (monetary or otherwise) that you may incur. The information contained herein is based on sources that we believe to be reliable but is not guaranteed by us as being accurate and does not purport to be a complete statement or summary of the available data. Readers should always do their own due diligence and consult a financial professional. StockMarketIntel.com encourages readers and investors to supplement the information in these reports with independent research and other professional advice. All information on featured companies is provided by the companies profiled, or is available from public sources and StockMarketIntel.com makes no representations, warranties or guarantees as to the accuracy or completeness of the disclosure by the profiled company. Any opinions expressed on this website are statements of judgment as of the date of publication and are subject to change without further notice, and may not necessarily be reprinted in future publications or elsewhere.
Read Full disclaimer at: http://stockmarketintel.com/Disclaimer.htm
Copyright © 2005-2013 - SBWire, The Small Business Newswire - All Rights Reserved - Important Disclaimer
Contact Us: 888-4-SBWIRE (US) - 920-593-5640 (International)